JPH02138226A - ヒトの線維芽細胞インタフェロン含有医薬組成物 - Google Patents
ヒトの線維芽細胞インタフェロン含有医薬組成物Info
- Publication number
- JPH02138226A JPH02138226A JP1258989A JP25898989A JPH02138226A JP H02138226 A JPH02138226 A JP H02138226A JP 1258989 A JP1258989 A JP 1258989A JP 25898989 A JP25898989 A JP 25898989A JP H02138226 A JPH02138226 A JP H02138226A
- Authority
- JP
- Japan
- Prior art keywords
- interferon
- column
- units
- sepharose
- human fibroblast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6237179A | 1979-07-31 | 1979-07-31 | |
| US62371 | 1979-07-31 | ||
| US13063580A | 1980-03-14 | 1980-03-14 | |
| US130635 | 1993-10-01 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10379380A Division JPS5622794A (en) | 1979-07-31 | 1980-07-30 | Human fibroblast interferon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH02138226A true JPH02138226A (ja) | 1990-05-28 |
Family
ID=26742182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1258989A Pending JPH02138226A (ja) | 1979-07-31 | 1989-10-05 | ヒトの線維芽細胞インタフェロン含有医薬組成物 |
Country Status (33)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK170476B1 (da) | 1980-04-03 | 1995-09-11 | Biogen Inc | Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon |
| NZ198445A (en) * | 1980-09-25 | 1984-05-31 | Genentech Inc | Production of human fibroblast interferon by recombinant dna technology |
| ZA83768B (en) * | 1982-03-01 | 1983-10-26 | Hoffmann La Roche | Homogeneous human immune interferon and process therefor |
| US4966843A (en) * | 1982-11-01 | 1990-10-30 | Cetus Corporation | Expression of interferon genes in Chinese hamster ovary cells |
| US4569790A (en) * | 1984-03-28 | 1986-02-11 | Cetus Corporation | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
| US4530787A (en) * | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
| US4894330A (en) * | 1986-12-23 | 1990-01-16 | Cetus Corporation | Purification of recombinant beta-interferon incorporating RP-HPLC |
| US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| US20030026779A1 (en) * | 1999-10-15 | 2003-02-06 | Liming Yu | Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc |
| US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| US20050002902A1 (en) * | 1995-12-28 | 2005-01-06 | Liming Yu | Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections |
| US20080219952A1 (en) | 2005-08-26 | 2008-09-11 | Ares Trading S.A. | Process For the Preparation of Glycosylated Interferon Beta |
| JP5199112B2 (ja) | 2005-12-09 | 2013-05-15 | アレス トレーディング ソシエテ アノニム | Ｆｓｈ又はｆｓｈ変異体を精製するための方法 |
| CA2702448A1 (en) * | 2007-10-22 | 2009-04-30 | Merck Serono S.A. | Method for purifying fc-fusion proteins |
| DE102009032179A1 (de) | 2009-07-07 | 2011-01-13 | Biogenerix Ag | Verfahren zur Reinigung von Interferon beta |
-
1980
- 1980-07-01 ZA ZA00803943A patent/ZA803943B/xx unknown
- 1980-07-01 CH CH5082/80A patent/CH648331A5/de not_active IP Right Cessation
- 1980-07-23 FR FR8016227A patent/FR2462167B1/fr not_active Expired
- 1980-07-29 MC MC801460A patent/MC1337A1/fr unknown
- 1980-07-29 NZ NZ194495A patent/NZ194495A/en unknown
- 1980-07-29 HU HU801891A patent/HU185382B/hu unknown
- 1980-07-29 IL IL60697A patent/IL60697A/xx unknown
- 1980-07-29 PH PH24361A patent/PH17738A/en unknown
- 1980-07-29 CA CA000357224A patent/CA1146468A/en not_active Expired
- 1980-07-30 DE DE19803028919 patent/DE3028919A1/de active Granted
- 1980-07-30 PT PT71625A patent/PT71625B/pt unknown
- 1980-07-30 IE IE1589/80A patent/IE50075B1/en unknown
- 1980-07-30 AU AU60914/80A patent/AU536274B2/en not_active Expired
- 1980-07-30 NO NO802297A patent/NO151158C/no unknown
- 1980-07-30 GB GB8024889A patent/GB2055384B/en not_active Expired
- 1980-07-30 RO RO101841A patent/RO81474B/ro unknown
- 1980-07-30 AT AT0395080A patent/AT372387B/de not_active IP Right Cessation
- 1980-07-30 DK DK328880A patent/DK159825C/da not_active IP Right Cessation
- 1980-07-30 IT IT23801/80A patent/IT1132269B/it active
- 1980-07-30 ZW ZW179/80A patent/ZW17980A1/xx unknown
- 1980-07-30 NL NL8004361A patent/NL8004361A/nl not_active Application Discontinuation
- 1980-07-30 ES ES493849A patent/ES8200560A1/es not_active Expired
- 1980-07-30 LU LU82673A patent/LU82673A1/de unknown
- 1980-07-31 SE SE8005498A patent/SE466290B/sv not_active IP Right Cessation
- 1980-07-31 AR AR282016A patent/AR229931A1/es active
- 1980-07-31 FI FI802400A patent/FI70721C/fi not_active IP Right Cessation
- 1980-07-31 YU YU01934/80A patent/YU193480A/xx unknown
- 1980-08-01 DO DO1980002948A patent/DOP1980002948A/es unknown
-
1983
- 1983-10-21 PH PH29729A patent/PH18479A/en unknown
-
1984
- 1984-01-11 KE KE3364A patent/KE3364A/xx unknown
- 1984-05-10 HK HK403/84A patent/HK40384A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY274/85A patent/MY8500274A/xx unknown
-
1989
- 1989-07-14 US US07/386,088 patent/US5015730A/en not_active Expired - Lifetime
- 1989-10-05 JP JP1258989A patent/JPH02138226A/ja active Pending
Non-Patent Citations (3)
| Title |
|---|
| CANCER TREATMENT REPORTS=1978 * |
| J.BIOL.CHEM=1977 * |
| J.BIOL.CHEM=1978 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI69476B (fi) | Foerfarande foer rening av maenniskans leukocyt-interferon | |
| JP3438735B2 (ja) | 上清ｉｖ、特にｉｖ−４またはコーンフラクションｖまたはそれと類似の上清または画分からヒトアルブミンを単離する方法 | |
| CA1146468A (en) | Homogeneous fibroblast interferon and method for manufacture thereof | |
| HU212362B (en) | Methods for preparing coagulation factor ix and pharmaceutical compositions containing same | |
| KR0131204B1 (ko) | 암 면역치료용 보조제 | |
| NZ203364A (en) | Method for purifying human immune interferon;homogeneous human immune interferon | |
| US4617378A (en) | Purification of biologically active human immune interferon | |
| EP0446582A1 (en) | Method for producing of recombinant human cysteineless gamma-interferon free of methionine at n-terminal | |
| JPS6261040B2 (cg-RX-API-DMAC10.html) | ||
| US5114710A (en) | M-csf as a therapeutic agent for thrombocytopenia | |
| JPH02115196A (ja) | エリスロポエチンの精製法 | |
| JPH0224840B2 (cg-RX-API-DMAC10.html) | ||
| US4723000A (en) | Human interferon gamma and interleukin-2 | |
| JPWO1992014832A1 (ja) | ヒトｂｃｄｆの精製法 | |
| US20030148488A1 (en) | Method for the production of pure virally inactivated butyrylcholinesterase | |
| JPH0568583A (ja) | 組換えヒトβ−インターフエロンの精製方法 | |
| Herring et al. | Rapid purification of leukocyte interferons by high-performance liquid chromatography | |
| Miroshnikov et al. | Preparation of Interferon-γ and Deltaferon, Its Analogue |